Dr. Weyrich's Naturopathic Functional Medicine Notebook is a collection of information on topics of interest to Dr. Weyrich that may be of interest to the world wide audience. Due to limitations of time, not all information that Dr. Weyrich knows or would like to further research is published here. Dr. Weyrich welcomes financial contributions to support specific research topics, as well as copies of non-free access journal articles for him to review on a topic. Constructive criticism is also welcome.


Overview of Lymphoma

This web page discusses Hodgkin's and Non-Hodgkin's Lymphoma, which may or may not have the same mechanism as breast and prostate cancer.

Please see Cancer Overview for general information that is common to all forms of cancer.

Dr. Weyrich is not an expert in the treatment of cancer, but does offer supportive therapies to reduce pain and nausea, mitigate the side effects, and to generally boost the immune system.

Complimentary and alternative treatments for Hodgkin's and non-Hodgkin's lymphoma that are considered below include:

  • Low Dose Naltrexone

Treatment of Lymphoma

Please see conventional, complimentary and alternative medical treatments for important background information regarding the different types of medical treatments discussed below.

Naturopathic, Complimentary and Alternative Treatments

Low Dose Naltrexone (LDN)

According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit Hodgkin's and Non-Hodgkin's Lymphoma. [LDN_Cancer] reports that the late Dr. Bernard Bihari treated approximately 450 patients with some form of cancer, with a 60% success rate, almost all of who had failed to respond to standard treatments. In particular, 6 patients with non-Hodgkin's lymphoma and 3 patients with Hodgkin's disease appeared to be in remission. In one case of Non-Hodgkin's Lymphoma in a 75 year old woman, the oncologist chose "watchful waiting" and the patient took LDN; 6 months later tumor size had shrunk by 50%, and subsequently shrank over the next 11 months by a total of 80%. In another case of Non-Hodgkin's Lymphoma, after 3 months of LDN use the involved nodes had shrunk in size by 33%, and subsequently shrank further by a total of 50% without any conventional treatment. In a case of Hodgkin's disease, complete remission was maintained during a 5.5-year follow-up period.

Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN). However, Dr. Weyrich has not treated any cases of Lymphoma with LDN.

Please see What is Low Dose Naltrexone? for more information.

It is believed that LDN works by temporarily blocking the body's opioid receptors, which induces a reflex increase in the body's natural endorphin and enkephalin levels, which then target the tumors' opioid receptors and induce apoptosis (programmed cell death) of the cancer cells. The endorphins and enkephalins also increase natural killer cells and other immune responses against the cancer cells [Mathews1983].

The main caveats are that patients cannot also be being treated with extended release opiates for pain control and cannot be organ transplant recipients. This is an off-label use, and as such is not likely to be covered by insurance.

Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN) and offers these protocols as a complement to other therapies; however at this time Dr. Weyrich has not treated any cases of lymphoma.


References for Lymphoma